Is Datasea Intelligent Technology Ltd. (DTSS) a Buy, Sell, or Hold?
NASDAQ : DTSS
Datasea Intelligent Technology Ltd. — News
$0.8001 USD
$0.05 (6.5%)
- Volume
- 44.67K
- Average Volume
- 295.23K
- Market Capitalization
- $8.36M
- P/E Ratio
- -2.22
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $2.50
- Year Low
- $0.58
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.60
| Source | Headline |
|---|---|
|
Datasea Intelligent Technology Ltd. Announces CEO's Intention to Purchase Up to US$1.0 Million of the Company's Class A Ordinary Shares
BEIJING, June 16, 2026 /PRNewswire/ -- Datasea Intelligent Technology Ltd. (Nasdaq: DTSS) ("Datasea" or the "Company"), a technology company focused on acoustic high-tech and AI multimodal digital solutions, today announced that Ms. prnewswire.com - 2026-06-16 09:30:00 |
|
Datasea Intelligent Technology Ltd. Announces Advancement of Compliance Work and Related Procedures for U.S. FDA Establishment Registration and Device Listing for Its Acoustic Brain-Computer Interface
Datasea Intelligent Technology Ltd. Announces Advancement of Compliance Work and Related Procedures for U.S. FDA Establishment Registration and gurufocus.com - 2026-06-12 13:00:00 |
|
Datasea Intelligent Technology Ltd. Announces Advancement of Compliance Work and Related Procedures for U.S. FDA Establishment Registration and Device Listing for Its Acoustic Brain-Computer Interface Product
Company Advances Preparatory Work for Internationalization of Its Acoustic Medical and Brain-Computer Interface Product Portfolio BEIJING, June 12, 2026 /PRNewswire/ -- Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company focused on acoustic high-tech innovation and AI-powered multimodal digital solutions, today announced that the Company is advancing compliance work and related procedures required for U.S. Food and Drug Administration ("FDA") establishment registration and device listing for one of its acoustic brain-computer interface ("BCI") products. prnewswire.com - 2026-06-12 12:15:00 |
